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Background
Arterial stiffness is one of the most potent prognostic
factors of cardiovascular morbidity and mortality. Its
surrogate parameter, pulse wave velocity (PWV), is most
commonly assessed by carotid-femoral applanation
tonometry (AT). Limited availability of the AT equip-
ment limits its application in clinical practice. Phase
contrast cardiac magnetic resonance (CMR) offers
insight in arterial stiffness at no extra cost, without sig-
nificant protocol extension. As CMR accessibility
increases, validated post-processing tools for CMR-
derived PWV measurement are needed.
The aim of the study was to provide a validated, freely
available tool to measure PWV using a routine CMR
protocol.
Methods
AT- and CMR-derived PWV measurements were com-
pared in 21 subjects (10 healthy subjects aged 28±8 (16-
44) yrs in whom cardiovascular disease was excluded
based on clinical assessment and CMR result and 11
patients with hyperlipidemia and/or hypertension aged
57,8 ± 7,5 yrs).
AT-derived PWV measurements were done by the caro-
tid [C] and femoral [F] applanation pulse wave recording
and body surface approximation of the distance travelled
(suprasternal notch to [F] - suprasternal notch to [C]),
using SphygmoCor, (AtCor Medical, Australia). Phase
contrast CMR images were acquired with a 3T or a 1,5T
scanner (Achieva 3T TX, Philips, or Aera 1,5T, Siemens),
and PWV was assessed, based on ascending and thoracic
aortic flow data and direct aortic length measurements. In
addition to scanning patients and healthy subjects, compu-
ter phantoms were constructed based on true aortic curves
and known time delays. A PWV quantification method
based on curve foot transit time was implemented in the
software Segment (http://segment.heiberg.se).
Results
Mean AT-PWV values were 5.54±0.65 m/s and 8.0±1.65
m/s and mean CMR-PWV were 4.15±0.79 m/s and
8.19±2.60 m/s in healthy subjects and in patients,
respectively. CMR-PWV agreed well with AT-PWV
measurements (Figure 1, left panel, R=0,77). For CMR-
PWV there were overlap with one patients compared to
normals, whereas there was an overlap with three
patients for AT-PWV (Figure 1, right panel). Intraobser-
ver variability of CMR-PWV was -0.03±0.57 m/s, and
inter observer variability was 0.09±0.49 m/s. From the
phantom experiments it was found that in order to
accurately quantify higher PWVs, a time resolution of at
least 40 timeframes is required (Figure 2).
Conclusions
A freely available tool for CMR-derived PWV measure-
ment was successfully validated against applanation tono-
metry as well as in phantom studies. These results indicate
that aortic PWV measurements incorporated in a routine
CMR examination correlate well with carotid-femoral AT-
PWV measurements in individuals without detectable car-
diovascular disease and in patients. CMR-derived PWV
analysis has low intraobserver and interobserver variability,
both in healthy subjects and in patients.
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Figure 1 AT-PWV and CMR-PWV correlation plot (left, R=0,77) and PWV value distribution in the two subgroups by both methods.
Figure 2 Results from phantom experiments with different number of time frames in the measured phase contrast images.
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